Modulation of major histocompatibility class II protein expression by varicella-zoster virus
about
Antiviral actions of interferonsVaricella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivoRespiratory syncytial virus impairs macrophage IFN-alpha/beta- and IFN-gamma-stimulated transcription by distinct mechanisms.Varicella-Zoster virus pathogenesis and immunobiology: new concepts emerging from investigations with the SCIDhu mouse model.T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infectionCD4 T cell immunity is critical for the control of simian varicella virus infection in a nonhuman primate model of VZV infection.Cell surface major histocompatibility complex class II proteins are regulated by the products of the gamma(1)34.5 and U(L)41 genes of herpes simplex virus 1.Varicella-zoster virus (VZV) ORF17 protein induces RNA cleavage and is critical for replication of VZV at 37 degrees C but not 33 degrees C.Identification of an important immunological difference between virulent varicella-zoster virus and its avirulent vaccine: viral disruption of dendritic cell instructionRelationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B.Subversion of B lymphocyte signaling by infectious agents.Adaptive and innate transforming growth factor beta signaling impact herpes simplex virus 1 latency and reactivationVaricella Viruses Inhibit Interferon-Stimulated JAK-STAT Signaling through Multiple MechanismsKaposi's sarcoma-associated herpesvirus inhibits expression and function of endothelial cell major histocompatibility complex class II via suppressor of cytokine signaling 3Varicella-zoster virus modulates NF-kappaB recruitment on selected cellular promotersHerpesvirus interference with major histocompatibility complex class II-restricted T-cell activation.Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites.T-cell immunity to human alphaherpesviruses.Humoral and cellular immunity to varicella-zoster virus: an overview.Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaquesImmune-Related Gene Expression Patterns in GPV- or H9N2-Infected Goose Spleens.Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.Varicella zoster virus immune evasion strategies.Molecular studies of the Oka varicella vaccine.Herpesviruses placating the unwilling host: manipulation of the MHC class II antigen presentation pathway.Clinical and molecular aspects of the live attenuated Oka varicella vaccine.Cell Signaling Pathways That Regulate Antigen PresentationVaricella-zoster virus infection of human dendritic cells and transmission to T cells: implications for virus dissemination in the host.Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.Simian varicella virus inhibits the interferon gamma signalling pathway.Kaposi's sarcoma-associated herpesvirus-encoded viral IRF3 modulates major histocompatibility complex class II (MHC-II) antigen presentation through MHC-II transactivator-dependent and -independent mechanisms: implications for oncogenesis.Specific inhibition of interferon signal transduction pathways by adenoviral infection.Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression.Mycobacterium avium subsp. paratuberculosis inhibits gamma interferon-induced signaling in bovine monocytes: insights into the cellular mechanisms of Johne's disease.Properties and Immune Function of Cardiac Fibroblasts.Cellular Stress Response to Varicella-Zoster Virus Infection of Human Skin Includes Highly Elevated Interleukin-6 ExpressionDifferential HLA Gene Expression in Measles Vaccine Seropositive and Seronegative Subjects: A Pilot Study
P2860
Q24550676-C3331365-FEB1-4FC2-A7B4-C50202309970Q28363307-C72B811B-704D-4F96-8362-0FB52F83714FQ30531746-E3283C97-B753-47F2-A1CC-35A736E796ABQ33766415-32599C05-8FF2-4891-9A0F-DFC7DA9B6ACDQ33833934-D560990A-4543-4681-A3A6-611B274A18EAQ34045556-4D8A720C-B666-46BC-9B89-4065112320F3Q34079162-7B441976-582E-4C30-9E4B-CCE881B82918Q34341979-C90B3526-E90E-463B-9BD5-17178D2E8E94Q34349183-7A4DCA91-7169-4075-8198-BCE508E00B69Q34549746-6967F61A-2AAF-4570-AEF5-59849F2D3ED6Q34604716-37962572-7E83-44D8-8704-80B685FDD6F1Q35078625-6EC9B066-B401-4AA5-BC62-D8D16DED38E7Q35363452-4E836506-9338-4095-83DF-F342AF9330B4Q35606690-25B612C3-44BF-4146-97BE-95FDB47DF943Q36155542-0B49D7A6-59E0-49E5-8E45-502DA4DBBCD1Q36315805-36D9672C-5A75-424E-A166-AD18FB359861Q36641746-FD98140A-DED9-4375-815C-FCBE6EDA8790Q37094247-5B0D6D07-C391-4931-97C3-2ECE54782334Q37107189-6D226D57-5196-4F07-8229-A727CB786AB0Q37141183-9B39B518-0AB7-4A5C-B1C5-C2C031006F68Q37252780-3F571842-E116-4DF7-B0B2-7435A407EF62Q37534555-4F68E891-C903-4E89-BBEE-E2685C800D36Q37559627-87FEB78D-D347-4313-9FCE-D963315B68C8Q37585469-FAB0A535-BBAD-4B29-A3F4-3AC049A5A19BQ37606051-F1461800-EADC-4B21-8E1C-582690B498F6Q37932527-486F34A3-826B-43FE-A3D8-FD6BD3781D87Q38046606-4D8D749B-7910-412D-BAB7-8F8454C0EFCBQ38200971-FB8079AD-40E5-47B0-866C-ED3B6270C1AAQ39002838-E8A07A32-0E65-4EE4-B88F-E4B468B8EE76Q39603314-73A1F0EE-1555-43F6-A67E-A464D91B194BQ39742020-BBC2263A-D7C9-4BA2-84FA-4C3E85AEFEA7Q40043931-A84BF385-475E-4EEC-BD09-AED9934A2CC2Q40529241-EC1CE004-81DA-4888-836A-F4FF24CD6E1BQ40773522-DFB8AE9E-D161-438E-A23B-A59DBA65268BQ42059350-E775791A-769B-477D-84CC-4C2FA6D4DA8DQ42275433-F8EF7C32-D0AD-4469-83F0-0C70AD5B8056Q51835859-BD511171-E67C-448F-936D-9B3D25DE3FB5Q57023788-E539125B-3516-4C6F-B0D7-20C878AC9A42Q57157989-00E9451C-71D9-423F-AB63-BA7BB9601B70
P2860
Modulation of major histocompatibility class II protein expression by varicella-zoster virus
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Modulation of major histocompa ...... sion by varicella-zoster virus
@ast
Modulation of major histocompa ...... sion by varicella-zoster virus
@en
type
label
Modulation of major histocompa ...... sion by varicella-zoster virus
@ast
Modulation of major histocompa ...... sion by varicella-zoster virus
@en
prefLabel
Modulation of major histocompa ...... sion by varicella-zoster virus
@ast
Modulation of major histocompa ...... sion by varicella-zoster virus
@en
P2093
P2860
P1433
P1476
Modulation of major histocompa ...... sion by varicella-zoster virus
@en
P2093
P2860
P304
P356
10.1128/JVI.74.4.1900-1907.2000
P577
2000-02-01T00:00:00Z